Hartung, Hans-Peter
Aktas, Orhan http://orcid.org/0000-0002-2020-9210
Article History
First Online: 22 May 2020
Competing interests
: H.-P.H. has received personal fees for membership in steering and data monitoring committees from Bayer Healthcare, Biogen, Celgene Receptos, Geneuro, Medimmune, Merck, Novartis, Roche, Teva, TG Therapeutics, VielaBio with the approval of the Rector of Heinrich-Heine-University. O.A. has received, with approval of the Rector of Heinrich-Heine University, grants from the German Research Foundation (DFG), the German Ministry for Education and Research (BMBF) as part of the German Competence Network Multiple Sclerosis (KKNMS; for NEMOS NationNMO-PAT FKZ 01GI1602B), the Eugène Devic European Network (EU-FP7), honoraria and travel/accommodation/meeting expenses from Almirall, Bayer, Biogen, Medimmune, Merck Serono, Novartis, Roche, Sanofi-Genzyme and Teva.
Free to read: This content has been made available to all.